A Selective COX-2 Inhibitor Inhibits CXC Chemokine Production in Human Pancreatic Cancer Cells

被引：0
|
作者：
Satake, M. [1 ,2 ]
Kuroda, N. [1 ]
Uyama, N. [1 ]
Hirano, T. [1 ]
Okada, T. [1 ]
Eibl, G. [2 ]
Go, V. L. [2 ]
Hines, O. J. [2 ]
Reber, H. [2 ]
Fujimoto, J. [1 ]
机构：
[1] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
PANCREAS | 2010年 / 39卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1345 / 1345
页数：1
相关论文
共 50 条
  • [41] Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor
    Chen, WS
    Liu, JH
    Wei, SJ
    Yang, WK
    CANCER GENE THERAPY, 2003, 10 : S41 - S41
  • [42] Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor
    Chen, WS
    Liu, JH
    Wei, SJ
    Liu, JM
    Hong, CY
    Yang, WK
    CANCER SCIENCE, 2003, 94 (03) : 253 - 258
  • [43] COX-2 inhibition increases chemokine production and splenocyte proliferation in a model of colorectal cancer
    Walmesley, AJ
    Christmas, SE
    Watson, AJM
    GASTROENTEROLOGY, 2004, 126 (04) : A279 - A279
  • [44] Expression of COX-2 confers growth advantage to pancreatic cancer cells
    Li, Aihua
    Hasan, Sascha
    Angst, Eliane
    Reber, Howard A.
    Hines, Oscar J.
    Eibl, Guido
    GASTROENTEROLOGY, 2008, 134 (04) : A452 - A452
  • [45] Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: Independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration
    Kuipers, Gitta K.
    Slotman, Ben J.
    Wedekind, Laurine E.
    Stoter, T. Rianne
    Van Den Berg, Jaap
    Sminia, Peter
    Vincent, M.
    Lafleur, M.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2007, 83 (10) : 677 - 685
  • [46] Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
    Antoniou, Katerina
    Malamas, Michael
    Drosos, Alexandros A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1719 - 1732
  • [47] Discovery of the COX-2 selective inhibitor celecoxib.
    Talley, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [48] Etoricoxib, a selective COX-2 inhibitor, in primary dysmenorrhea
    Malmstrom, K
    Daniels, S
    McGratty, M
    Kotey, P
    Jacobsen, AR
    Desjardins, PJ
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 59S - 59S
  • [49] Valdecoxib: A highly selective and potent inhibitor of COX-2
    Gierse, JK
    Koboldt, C
    Hood, B
    Zhang, Y
    Zweifel, B
    Kurumbail, R
    Kiefer, J
    Pawlitz, J
    Walker, M
    Isakson, P
    Seibert, K
    FASEB JOURNAL, 2002, 16 (04): : A181 - A182
  • [50] Lumiracoxib (Prexige®):: a new selective cox-2 inhibitor
    Mysler, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (06) : 606 - 611
12345